Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Activation of RalA is critical for Ras-induced tumorigenesis of human cells.

Cancer cell | Jun 13, 2005

http://www.ncbi.nlm.nih.gov/pubmed/15950903

RalGEFs were recently shown to be critical for Ras-mediated transformed and tumorigenic growth of human cells. We now show that the oncogenic activity of these proteins is propagated by activation of one RalGEF substrate, RalA, but blunted by another closely related substrate, RalB, and that the oncogenic signaling requires binding of the RalBP1 and exocyst subunit effector proteins. Knockdown of RalA expression impeded, if not abolished, the ability of human cancer cells to form tumors. RalA was also commonly activated in a panel of cell lines from pancreatic cancers, a disease characterized by activation of Ras. Activation of RalA signaling thus appears to be a critical step in Ras-induced transformation and tumorigenesis of human cells.

Pubmed ID: 15950903 RIS Download

Mesh terms: ATP-Binding Cassette Transporters | Animals | Carrier Proteins | Cell Line | Cell Line, Tumor | Cell Proliferation | Cell Transformation, Neoplastic | GTPase-Activating Proteins | Gene Expression | Guanosine Triphosphate | Humans | Mice | Mice, SCID | Neoplasm Transplantation | Neoplasms | Pancreatic Neoplasms | Protein Binding | Protein Transport | Proto-Oncogene Proteins p21(ras) | RNA, Small Interfering | Transfection | Vesicular Transport Proteins | ral GTP-Binding Proteins | ral Guanine Nucleotide Exchange Factor | rho GTP-Binding Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA42978
  • Agency: NCI NIH HHS, Id: CA94184

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.